Lavazza unveils its 2026 Calendar, Pleasure Makes Us Human, continuing the brand’s global narrative celebrating pleasure as a defining element of humanity. For the first time, the Calendar is presented to the public at Art Basel Miami Beach, reinforcing Lavazza’s long-standing relationship with art and photography. This edition sees Lavazza entrust the creative direction to […] The post PLEASURE MAKES US HUMAN: LAVAZZA UNVEILS THE 2026 CALENDAR BY ALEX WEBB appeared first on Web-Release.

    Today at CES 2026, AMD (NASDAQ: AMD) unveiled its latest generation of mobile and desktop processors that expand its client computing portfolio, bringing expanded AI capabilities, premium gaming performance, and commercial-ready features to more systems than ever before. AMD introduced the new AMD Ryzen™ AI 400 Series for Copilot+ PCs, Ryzen™ AI Max+ processors for premium ultra-thin […] The post AMD Expands AI Leadership Across Client, Graphics, and Software with New Ryzen, Ryzen AI, and AMD ROCm Announcements at CES 2026 appeared first on Web-Release.

    Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.